BioCentury
ARTICLE | Clinical News

Aviron regulatory update

July 18, 1994 7:00 AM UTC

Aviron Aviron and the University of Chicago's techology transfer arm, ARCH Development Corp., received U.S. Patent No. 5,328,688 covering genetically engineered herpes simplex viruses (HSV) that may ...